1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1630
  5. Art Unit 1633
  6. Examiner Levin

Examiner Levin Joel D

1633-LEVIN-JOEL-D

Employment Information

Art Unit:1633 — Drug, bio-affecting and body treating compositions
Group:1630 — Stem cells and cell culture and Nucleic Acid related therapy
Classes: 435 — Chemistry: molecular biology and microbiology
424 — Drug, bio-affecting and body treating compositions
800 — Multicellular living organisms and unmodified parts thereof and related processes
536 — Organic compounds -- part of the class 532-570 series
382 — Image analysis
514 — Drug, bio-affecting and body treating compositions
Phone:(571) 270-0616
Email:None
Location:None
Title:Pat Examnr (Biolgy)
Service:3 years
Grade:GS-11

Grant Rate and Difficulty Ranking

3-Year Grant rate: 0% over 6 cases
Difficulty: Not enough data to rank
Difficulty Percentile:

With Examiner Levin, you have a 0% chance of getting an issued patent by 3 years after the first office action.

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Levin, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1633

Examiner Levin's grant rate is lower than that of Art Unit 1633 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Levin 2.1
Art Unit 1633 2.0

Interview Benefit

Grant Rate without Interview

Examiner Levin has granted 0 of 4 cases without any applicant-requested interviews for a grant rate of 0%.

Grant Rate with Interview

Examiner Levin has granted 0 of 2 cases with at least one applicant-requested interview for a grant rate of 0%.

Interview Benefit

With Examiner Levin, conducting an interview increases your chance of getting a patent granted by 100%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17755757 Methods For Producing Or Isolating Epicardial Cells And Uses Thereof Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
17309177 Treatment Of Cachexia Using Fibroblast Cells And Products Thereof Patented View
17583918 Tissue Stem Cell Counting Algorithms And Uses Thereof Abandoned View
17808161 Compositions, Methods, Kits, Cartridges, And Systems For Sequencing Reagents Patented View
17422266 Pharmaceutical Composition Using Endogenous Cells For Preventing Or Treating Musculoskeletal Disorders Patented View
17269369 Mobilization And Collection Of Peripheral Blood Hematopoietic Stem Cells And Lymphocytes From Deceased Donors Patented View
16702560 Formulation Comprising Extracellular Vesicles, Method For Producing The Same, And Uses Thereof Patented View
17416962 Method Of Producing Enteric Neurons And Uses Thereof Abandoned View
17783694 Methods For Generating Hematopoietic Stem Cells Abandoned View
17291556 Method Of Determining Responsiveness To Cell Therapy In Dilated Cardiomyopathy Patented View
17286019 Hair Rejuvenation Abandoned View
17422677 Human Umbilical Cord Mesenchymal Stem Cell Sheets And Methods For Their Production Abandoned View
16339059 Fgf21 Responsive Reporter Gene Cell Line Patented View
17422601 Solution For Preserving Biological Samples And Use Of Such Solution Abandoned View
17777359 Composition For Treating Spinal Cord Injury, Comprising Stem Cells Treated With Novel Compound Patented View
17282090 Compositions Comprising Small Extracellular Vesicles Derived From Umbilical Cord Blood Mononuclear Cells With Anti-Inflammatory And Immunomodulatory Properties And Process For Obtaining Them Patented View
17292162 In Vitro Cell Culture System For Producing Hepatocyte-Like Cells And Uses Thereof Abandoned View
17550839 Mice That Make Vl Binding Proteins Patented View
17309316 A Modular, Polycistronic Vector For Car And Tcr Transduction Abandoned View
17418619 Methods For Regulating Potency Of Pluripotent Stem Cells And Applications Thereof Abandoned View
17401765 Nucleic Acid Molecules Containing Spacers And Methods Of Use Thereof Patented View
17629770 Transgenic Cloned Pig For Xenotransplantation Expressing Human Cd46 And Tbm Genes, In Which Porcine Endogenous Retrovirus Envelope C Is Negative And Ggta1, Cmah, Igb3s And SS4galnt2 Genes Are Knocked Out, And Method For Preparing Same Abandoned View
17271469 Compositions Comprising Cell-Delivered Vesicles And Uses Thereof Patented View
17419985 Method For Manufacturing Cell Suspension And Method For Manufacturing Adherent Cells Abandoned View
17627542 Mesenchymal Stem Cell Compositions Abandoned View
17292131 Animal Cell Growth Promoter, Culture Medium For Animal Cell Culture, And Animal Cell Culture Apparatus Abandoned View
17621435 Methods Of Treating Pain Conditions And Compositions Related Thereto Abandoned View
17417991 Recombinant Human 2ig-B7-H3 Protein Coding Gene, Recombinant Vector, Host Cell Comprising The Same, Pharmaceutical Composition And Use Thereof Patented View
17542721 Optimized Parvovirus H-1 Production Patented View
17421129 Prophylactic And/or Therapeutic Agent For Diseases Accompanied By Fibrosis Abandoned View
17857754 Mesenchymal Stem Cells For Use In The Treatment Of Chronic Gingivostomatitis Abandoned View
17705237 Intravitreal Dosing For Delivery Of Polynucleotides To Retinal Cones Patented View
17052973 Bioengineering Tertiary Lymphoid Structures Using Chitosan-Based Hydrogels Patented View
17726347 Recombinant Sequence Specifically Expressing Human Beta-Globin In Erythroid Cells, And Use Thereof Abandoned View
17268989 Method For Generating Regulatory T Cells Abandoned View
17294006 Stem Cell-Derived Extracellular Vesicles And Methods Of Use Thereof Abandoned View
17422010 Stromal Cells Derived From Neonatal Felines And Uses Thereof Abandoned View
17580199 Multivalent Chlorotoxin Chimeric Antigen Receptors Abandoned View
17624760 Perfusate And Perfusion Method Abandoned View
17421678 Transgenic Barb Patented View
17255840 Mitochondrial Augmentation Therapy Of Liver Diseases Abandoned View
17017029 Innervated Intestine On Chip Abandoned View
17371002 Cd37-Antibody And Cd37-Car-T Cells Abandoned View
17287810 Partioning Of Adult Mesenchymal Stem Cells Patented View
17255757 Modular Biohybrid Systems And Methods Of Use Thereof Abandoned View
17286898 Silk Nucleotides And Proteins And Methods Of Use Patented View
17293608 Materials And Methods For Modifying Wolbachia And Paratransformation Of Arthropods Patented View
17413059 Pharmaceutical Composition For Preventing Or Treating Liver Disease, Comprising Bioimplant Comprising Mesenchymal Stem Cells Abandoned View
17281840 Accelerated Human Hematopoeitic Stem Cell Differentiation Towards Mature Natural Killer Cells With Enhanced Antibody-Dependent Cytotoxic Activity Abandoned View
17252556 Genome Engineering Primary Monocytes Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.